Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.

Source:http://linkedlifedata.com/resource/pubmed/id/9886376

J. Immunol. 1999 Jan 1 162 1 114-21

Download in:

View as

General Info

PMID
9886376